Exelixis
EXEL
377 hedge funds and large institutions have $5.69B invested in Exelixis in 2019 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 154 increasing their positions, 88 reducing their positions, and 47 closing their positions.
232% more call options, than puts
Call options by funds: $112M | Put options by funds: $33.6M
75% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 88
74% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 47
28% more capital invested
Capital invested by funds: $4.46B → $5.69B (+$1.24B)
10% more funds holding
Funds holding: 344 → 377 (+33)
3.02% more ownership
Funds ownership: 76.69% → 79.72% (+3%)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$115M |
| 2 |
Renaissance Technologies
New York
|
+$83.1M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$55.7M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$50.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$131M |
| 2 |
Millennium Management
New York
|
-$31.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$24.8M |
| 4 |
MG
Meditor Group
Hamilton,
Bermuda
|
-$19.9M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$16.8M |
EXEL Hedge Fund Activity: Q1 2019 in Review
377 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2019, worth a combined $5.69B — up 28% from $4.46B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new EXEL positions and 47 closed out — a net gain of 35 holders — while 154 added to existing stakes and 88 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $115M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $131M sold.
- 377 institutional investors held Exelixis (EXEL) as of Q1 2019, up from 344 in Q4 2018.
- Funds reported $5.69B of Exelixis stock for Q1 2019, up 28% quarter-over-quarter.
- 82 funds opened new Exelixis positions in Q1 2019 and 47 closed out, a net change of +35 holders.
- The largest Exelixis buyer in Q1 2019 was AQR Capital Management, an estimated $115M added.
- The largest Exelixis seller in Q1 2019 was Consonance Capital Management, an estimated $131M sold.
Based on aggregated 13F filings for Q1 2019.